Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|November 27, 2019
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate CancerJuan M Jiménez-Vacas, Enrique Gómez-Gómez, Antonio J Montero-Hidalgo, et al.
Brain : a Journal of Neurology|November 3, 2020
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3Antonio C Fuentes-Fayos, Mari C Vázquez-Borrego, Juan M Jiménez-Vacas, et al.
Journal of Cellular and Molecular Medicine|September 27, 2018
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancerEnrique Gómez-Gómez, Juan M Jiménez-Vacas, Julia Carrasco-Valiente, et al.
Plos One|January 28, 2014
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancerManel Puig-Domingo, Raúl M Luque, Jordi L Reverter, et al.
Cancer Gene Therapy|September 4, 2024
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinomaRicardo Blázquez-Encinas, Emilia Alors-Pérez, María Trinidad Moreno-Montilla, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 11, 2022
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 15, 2017
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancerDaniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Molecular Oncology|October 3, 2021
Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST<sub>5</sub> ) in pituitary and pancreatic neuroendocrine tumorsSergio Pedraza-Arevalo, Alejandro Ibáñez-Costa, Ricardo Blázquez-Encinas, et al.
Cancer Letters|October 4, 2016
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarkerDaniel Hormaechea-Agulla, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, et al.
Molecular Therapy. Nucleic Acids|January 8, 2024
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseEmilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, et al.
Pageof 15